Technical Analysis for BSGM - BioSig Technologies, Inc.

Grade Last Price % Change Price Change
grade A 8.86 1.37% 0.12
BSGM closed up 1.37 percent on Wednesday, June 26, 2019, on 55 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical BSGM trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction 1.37%
NR7 Range Contraction 1.37%
Inside Day Range Contraction 1.37%
Wide Bands Range Expansion 1.37%
Overbought Stochastic Strength 1.37%
Doji - Bearish? Reversal -1.56%
Upper Bollinger Band Walk Strength -1.56%

Older signals for BSGM ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
BioSig Technologies is a medical device company developing a proprietary biomedical signal processing technology designed to improve the $4.6 billion electrophysiology (EP) marketplace (www.biosigtech.com). Led by a proven management team and a veteran, independent Board of Directors, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP(TM) System. The technology has been developed to address an unmet need in a large and growing market. The Company’s first product, PURE EP(TM) System, is a novel cardiac signal acquisition and display system which is engineered to assist electrophysiologists in clinical decision making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig’s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias: Atrial Fibrillation and Ventricular Tachycardia. BioSig has partnered with Minnetronix on technology development and received FDA 510(k) clearance for the PURE EP(TM) System in August 2018.
FDA Circulatory System Atrial Fibrillation Cardiac Electrophysiology Cardiovascular System Cardiac Arrhythmia Technology Development Catheter Ablation Heart Arrhythmia Tachycardia
Is BSGM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.97
52 Week Low 3.5
Average Volume 237,760
200-Day Moving Average 5.5328
50-Day Moving Average 7.4274
20-Day Moving Average 7.637
10-Day Moving Average 8.588
Average True Range 0.6265
ADX 37.64
+DI 26.6956
-DI 8.9521
Chandelier Exit (Long, 3 ATRs ) 7.4092
Chandelier Exit (Short, 3 ATRs ) 7.9095
Upper Bollinger Band 9.7527
Lower Bollinger Band 5.5213
Percent B (%b) 0.79
BandWidth 55.406573
MACD Line 0.4979
MACD Signal Line 0.3286
MACD Histogram 0.1693
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.51
Resistance 3 (R3) 9.46 9.19 9.40
Resistance 2 (R2) 9.19 9.03 9.22 9.36
Resistance 1 (R1) 9.03 8.93 9.11 9.08 9.33
Pivot Point 8.76 8.76 8.81 8.79 8.76
Support 1 (S1) 8.60 8.60 8.68 8.65 8.39
Support 2 (S2) 8.33 8.50 8.36 8.36
Support 3 (S3) 8.17 8.33 8.32
Support 4 (S4) 8.22